Aerie Pharmaceuticals, Inc. (AERI)
  • CONTENT
Aerie Pharmaceuticals, Inc. (AERI)
Aerie Pharmaceuticals, Inc. (AERI)
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Monday, February 25, 2019
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye announced today that …
Aerie Pharmaceuticals, Inc. (AERI)